Acadian Asset Management LLC Relmada Therapeutics, Inc. Put Options Transaction History
Acadian Asset Management LLC
- $48.4 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RLMD
# of Institutions
49Shares Held
4.97MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY573KShares$338,2550.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$292,1360.03% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD397KShares$233,9430.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$214,8050.0% of portfolio
-
Geode Capital Management, LLC Boston, MA302KShares$178,3880.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $16.9M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...